NEW: The AAPM&R Evidence-Based Medicine Course
FREE Webinar: Preserving Access to Medicare-Covered Wheelchairs: Complying with Documentation & Coverage Requirements - June 8
Well Care Compounding Pharmacy Issues Voluntary Statewide Recall of All Sterile Compounded Products Due to Lack Of Assurance if Sterility Concerns
Young Investigators Urged to Apply for USBJI Grant Mentoring Program
BiCNU (carmustine for injection): FDA Alert - Counterfeit Product Discovered in Some Foreign Countries
Inpatient Rehab Recommended for Stroke Rehab
Take Our Quick MACRA Poll
PharMEDium Sterile Preparations Compounded With a Single Recalled Lot of Fresenius Kabi Sensorcaine-MPF (bupivacaine HCl): Recall - Presence of Glass Particulate Matter
CDC Releases New Research and HEADS UP Fact Sheet on Playground Safety
CMSS Spring 2016 Meeting Report
HIPAA Audit Updates - Privacy, Security, and Breach Notification Rules
Check Your Mailbox for the May Issue of The Physiatrist
Aripiprazole (Abilify, Abilify Maintena, Aristada): Drug Safety Communication - FDA Warns About New Impulse-control Problems
AAPM&R and KZA Help Physicians and Coders Master Coding and Reimbursement in Chicago
May is American Stroke Month
CMS Issues Proposed Rule for an Extensive Change in Physician Payment Policies
AAPM&R Signs On to Letter to CMS on Proposed Rule on Program Integrity Enhancements to the Provider Enrollment Process
Sensorcaine-MPF (bupivacaine HCl) by Fresenius Kabi: Recall - Presence of Particulate Matter
Sterile Drug Products from Pharmakon Pharmaceuticals, Inc: CDER Statement - FDA alerts health care professionals not to use due to a lack of sterility assurance and other quality issues
AAPM&R Members in the News: April 2016